Large Molecule

Articles

The elephant in the biopharma classroom

Biopharma needs to address its workforce training methods
China’s single-use craze

Can SUT hang on to its momentum in the next decade, or will stainless steel bioreactors rise again?
Pharma's high hopes

Some dreams need to be tethered with a plan
BIO 2019: It starts with one

This year's conference showed how incremental investments can make a global impact

Special Report: The Time is Right for Virtualization

Posted: May 03, 2017

Author: pepperl+fuchs

In this special report, we explore how virtualization can provide significant advantages for deploying process control systems at pharmaceutical plants.
Special Report: Addressing Process Contamination Risks

Posted: Apr 24, 2017

Author: WIKA

The high risk involved with biopharmaceuticals means there are high demands placed on the hygienic design of bioprocessing equipment. Instrument connections on equipment -- commonly used to position measurement instruments in the process flow for accurate
2016 Liquid Dose Trends

Posted: Aug 26, 2016

Parenteral drugs are taking a strong position alongside the more established oral solid dose forms and are quickly coming into their own.
eBook: Biopharmaceutical Technical Resource Guide

Posted: Dec 20, 2015

Biopharma R&D spending by PhRMA members grew from $2 billion in 1980 to some $51.6 billion in 2013. While no one’s crystal ball can exactly predict where the industry is headed, it is clear that Biopharma is soaring.

More News